Scrophuloside A5



Compound IDCDAMM02818
Common nameScrophuloside A5
IUPAC name[5-acetyloxy-6-[[2-(hydroxymethyl)-10-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,9-dioxatricyclo[4.4.0.02,4]dec-7-en-5-yl]oxy]-4-[3-(4-methoxyphenyl)prop-2-enoyloxy]-2-methyloxan-3-yl] 3-(4-methoxyphenyl)prop-2-enoate
Molecular formulaC43H50O19

Experimental data

Retention time27.54
Adduct[M+H]+
Actual mz871.306
Theoretical mz871.302
Error4.27
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score9.106

Identifiers and class information

Inchi keyBUIPMVNSPLYJFB-MAROVXGQNA-N
SmilesO=C(OC1C(OC(OC2C3OC3(CO)C4C(OC=CC24)OC5OC(CO)C(O)C(O)C5O)C(OC(=O)C)C1OC(=O)C=CC6=CC=C(OC)C=C6)C)C=CC7=CC=C(OC)C=C7
SuperclassPhenylpropanoids and polyketides
ClassCinnamic acids and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)11
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)22
Number of reactive functional groups (#rtvFG)7
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)870.857
Computed dipole moment(dipole)14.615
Total solvent accessible surface area (SASA)1152.26
Hydrophobic component of SASA (FOSA)611.821
Hydrophilic component of SASA (FISA)270.789
Pie component of the SASA (PISA)269.645
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)2393.28
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)25.5
Free energy of solvation of dipole (dip^2/V)0.0892508
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0442611
Globularity descriptor (glob)0.750953
Predicted polarizability in cubic angstroms (QPpolrz)78.074
Predicted hexadecane/gas partition coefficient (QPlogPC16)25.053
Predicted octanol/gas partition coefficient (QPlogPoct)47.617
Predicted water/gas partition coefficient (QPlogPw)32.291
Predicted octanol/water partition coefficient (QPlogPo/w)1.696
Predicted aqueous solubility (QPlogS)-3.937
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.174
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.848
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)26.792
Predicted brain/blood partition coefficient (QPlogBB)-3.964
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)9.89
Predicted skin permeability, log Kp (QPlogKp)-3.448
PM3 calculated ionization potential (IP(ev))8.974
PM3 calculated electron affinity (EA(eV))0.785
Number of likely metabolic reactions (#metab)8
Prediction of binding to human serum albumin (QPlogKhsa)-1.009
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)36.517
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)269.29
Number of nitrogen and oxygen atoms (#NandO)19
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P07900HSP90AA1Heat shock protein HSP 90-alphaT18477SwissTargetPrediction
P15692VEGFAVascular endothelial growth factor AT20761SEA
P05230FGF1Acidic fibroblast growth factorT18639SEA
P09038FGF2Basic fibroblast growth factorT31621SEA
P60568IL2Interleukin-2T61698SEA
P17931LGALS3Galectin-3T72038SEA
P04746AMY2APancreatic alpha-amylaseT86918SEA
P14679TYRTyrosinaseT97035SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T18477DI0015Acute upper respiratory infection[ICD-11: CA07]P07900HSP90AA1
T18477DI0037Asthma[ICD-11: CA23]P07900HSP90AA1
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T18639DI0081Chronic arterial occlusive disease[ICD-11: BD4Z]P05230FGF1
T18639DI0102Coronary atherosclerosis[ICD-11: BA52]P05230FGF1
T31621DI0005Acne vulgaris[ICD-11: ED80]P09038FGF2
T61698DI0275Multiple sclerosis[ICD-11: 8A40]P60568IL2
T61698DI0361Renal cell carcinoma[ICD-11: 2C90]P60568IL2
T72038DI0190Hypertension[ICD-11: BA00-BA04]P17931LGALS3
T72038DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]P17931LGALS3
T72038DI0252Melanoma[ICD-11: 2C30]P17931LGALS3
T72038DI0302Non-alcoholic fatty liver disease[ICD-11: DB92]P17931LGALS3
T72038DI0351Psoriasis[ICD-11: EA90]P17931LGALS3
T86918DI0110Cystic fibrosis[ICD-11: CA25]P04746AMY2A
T86918DI0328Pancreatic malfunction[ICD-11: DC30-DC3Z]P04746AMY2A
T97035DI0007Acquired hypermelanosis[ICD-11: ED60]P14679TYR
T97035DI0008Acquired hypomelanotic disorder[ICD-11: ED63]P14679TYR

Copyright © 2025